These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3661292)

  • 1. Arterial thromboembolism: valvular heart disease and prosthetic heart valves.
    Dalen JE
    Adv Exp Med Biol; 1987; 214():265-70. PubMed ID: 3661292
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic thromboembolism in valvular heart disease and prosthetic heart valves.
    Pumphrey CW; Fuster V; Chesebro JH
    Mod Concepts Cardiovasc Dis; 1982 Dec; 51(12):131-6. PubMed ID: 7155121
    [No Abstract]   [Full Text] [Related]  

  • 3. What is 'valvular' atrial fibrillation? A reappraisal.
    De Caterina R; Camm AJ
    Eur Heart J; 2014 Dec; 35(47):3328-35. PubMed ID: 25265975
    [No Abstract]   [Full Text] [Related]  

  • 4. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombotic treatment of patients with valvular atrial fibrillation].
    Bovin A; Christensen TD; Grove EL
    Ugeskr Laeger; 2017 Jul; 179(29):. PubMed ID: 28789760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
    Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Angoulvant D; Babuty D; Lip GY; Fauchier L
    Thromb Haemost; 2016 May; 115(5):1056-63. PubMed ID: 26843425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of prosthetic cardiac valves.
    Huse WM; Wareham EE
    Calif Med; 1967 Mar; 106(3):203-9. PubMed ID: 6039188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of arterial thromboembolic disease.
    Meyer BJ; Chesebro JH
    Curr Opin Hematol; 1994 Sep; 1(5):336-40. PubMed ID: 9371302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results with St. Jude Medical and CarboMedics prosthetic heart valves.
    Chang BC; Lim SH; Kim DK; Seo JY; Cho SY; Shim WH; Chung N; Kim SS; Cho BK
    J Heart Valve Dis; 2001 Mar; 10(2):185-194; discussion195. PubMed ID: 11297205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and pathogenesis of thromboembolism.
    Aronow WS
    Herz; 1991 Dec; 16(6):395-404. PubMed ID: 1765343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation after mitral valve replacement].
    Tseluyko VJ; Zhadan AV; Zedginidze ET
    Georgian Med News; 2015 Jan; (238):65-9. PubMed ID: 25693217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatment.
    Chesebro JH; Ezekowitz M; Badimon L; Fuster V
    Annu Rev Med; 1985; 36():579-605. PubMed ID: 3888065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial thromboemboli in rheumatic heart defects].
    Krivchenia DIu; Volkotrub AP; Voronkov LG; Zavodiĭ VG
    Klin Khir (1962); 1983 Jan; (1):48-52. PubMed ID: 6339793
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular heart disease, infected valves and prosthetic heart valves.
    Dalen JE
    Am J Cardiol; 1990 Feb; 65(6):29C-31C. PubMed ID: 2405624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
    Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Babuty D; Angoulvant D; Lip GY; Fauchier L
    Eur Heart J; 2015 Jul; 36(28):1822-30. PubMed ID: 25994754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atrial arrhytmias on the regurgitation of a monoleaflet prosthetic heart valve.
    Zapanta CM
    Artif Organs; 2005 Aug; 29(8):636-41. PubMed ID: 16048480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.